Clinical Trials Directory

Trials / Completed

CompletedNCT02342236

Cerebral Regional Oxygen Saturation and Markers of Brain Damage During Primary Hip Arthroplasty

The Regional Cerebral Oxygen Saturation and Both S100B and GFAP Proteins Serum Concentration in Patients Undergoing Primary Hip Arthroplasty.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Military Institute od Medicine National Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Postoperative Cognitive Disorders (POCD) are common in hospitalized people \> 60 year old, especially in orthopedic patients. Etiology of POCD is complex, and in some aspects still remains unclear. The role of thromboembolic events in etiology of POCD was discussed. The incidence of such events in patients who underwent big joints arthroplasty can be as high as 40 to 60%, although some cases are subclinical. Thromboembolic material can block a blood flow through a vessels in the brain. As a consequence cerebral neurons can be damaged or destroyed. After neuronal damage specific substances, such as S100B protein, glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE) are released to the blood. The serum concentrations of these biomarkers can be measured. Moreover, the block of blood flow will decrease regional cerebral saturation in affected parts of the brain. In this project the authors would like to analyze the correlation between the regional cerebral saturation and serum concentration of both S100B protein and GFAP in orthopedic patients scheduled to primary hip arthroplasty.

Conditions

Interventions

TypeNameDescription
DEVICEcemented or cementless type of hip prothesis

Timeline

Start date
2014-06-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-01-19
Last updated
2016-09-14

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT02342236. Inclusion in this directory is not an endorsement.